AC Immune SA Profit Margin

The latest profit margin for ACIU is -248.14% as of June 2026. That compares with -174.67% in the prior-year period — down 42.1% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside AC Immune SA's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACIU's profit margin moved from -174.67% to -248.14% — a 42.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AC Immune SA's valuation or profitability profile.

Against Healthcare companies, ACIU currently prints -248.14% for profit margin, while the sector average sits near 21.34%. That is roughly 1263.1% below the sector mean. Large gaps often invite a closer look at AC Immune SA's growth, margins, and balance sheet.

Profit Margin shows how effectively AC Immune SA converts resources into returns. At -248.14%, ACIU may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -174.67% in the prior-year period — down 42.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ACIU's profit margin (-248.14%), review year-over-year change from -174.67%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.